This study was carried out to formulate and evaluate controlled release (CR) matrix tablets of Acyclovir using combination of hydrophilic and hydrophobic polymers.
Introduction
The most frequently used route for administration of drugs is the oral route. The best and prevalent oral formulations available in the market are tablets and are favored by both patients and physicians equally. The most preferred formulations for chronic therapy are controlled release (CR) tablets for the reason that they offer better patient compliance [1] .
The main objective of controlled release formulation is to offer appropriate carriage profiles in the range of therapeutic window [2] [3] [4] .
The nature and characteristics of polymer play a significant role in release of Drug from reservoir, therefore their application can generate well branded dosage forms [1] .
Among the most predominant means for oral controlled delivery of drug is the system of hydrophilic matrix and the principal of release of drug from hydrophilic matrices is based on swelling of the polymer when it interacts with the aqueous medium. The release of drug occurs then by means of diffusion, dissolution, and erosion [5] [6] [7] [8] .
The success of Acyclovir in treating Herpes simplex virus (HSV) has prompted the synthesis of several structural analogs, but none has shown to be as tolerable as and have
shown to have such a high therapeutic index as acyclovir [9] .
The most extensively used drug for genital herpes, cutaneous herpes, chicken pox, varicella zoster and herpes keratitis infections is Acyclovir. Generally acyclovir is used as 200 mg tablets orally, five times a day [8] . Acyclovir is available in conventional immediate release tablet dosage form, Intravenous infusion (Zovirax ® ) and 3% ocular ointment, Liposomal, niosomal and magnet depot technology have also been investigated for the acyclovir by certain researchers [10, 11] . Ethyl cellulose is an important polymer excessively used as drug retarding ingredient in the formulating sustained and controlled release pharmaceutical drug products. Ethyl cellulose alters the length and size of the diffusion path thereby controlling the release of the drug from the dosage form.
Carbomer is soft and white colored powder which can easily absorb water forming thick solutions and/ or gels. Carbomer is an inert, unchanging or stable substance. It has no any toxic effects and repel putrefaction and spoilage.
Materials and Methods

Chemicals
Acyclovir was provided as a gift sample from Glitz Pharmaceuticals, Islamabad, Pakistan. Potassium Phosphate Monobasic and Sodium Hydroxide were purchased from CBW Chemie GmbH Bitterfeld-Wolfen, Germany, Magnesium Stearate and Lactose was obtained from BDH Chemical Ltd, Pool England while Ethocel and Carbopol were taken from Dow Chemical Co. Midland USA. All the stated above chemicals were used without any further purification.
Instruments
The following instruments were used during this project. Dissolution Apparatus (Curio Pak, DL 0702), UV-Visible Spectrophotometer (1800 Shimadzu, Japan), Single Punch Tablet Machine (ZT, China), Hardness Tester (Curio Pak, HT 0321), Friability Apparatus (Curio Pak, FB 0498), Disintegrating Apparatus (Curio Pak, DT 0601).
Construction of Standard Calibration Curve of Acyclovir
For stock solution preparation 25 mg of Acyclovir was taken in 50 ml (0.5 mg/ml) of manobasic phosphate buffer (pH 7.4) and was placed in ultra sonifier until the drug dissolution ensured completely. Suitable dilutions were prepared from the stock solution in descending order and then analyzed by means of UV-Spectrophotometer at λ max (254 nm). The corresponding absorbance values were noted and documented.
Chemical Integrity
FTIR spectra were measured for CR tablets of Acyclovir in order to investigate the effect on the functional group of Acyclovir. All samples were analyzed by a universal FTIR spectrum series at a resolution of 4 cm −1 . For this purpose one sample of suitable quantity of pure drug and other containing pure drug along with polymers and excipients.
Thermodynamic Behavior
The thermal behavior of the prepared pure acyclovir powder and CR tablets of Acyclovir (Pure Acyclovir+polymers) was tested by Differential Scanning Calorimeter (DSC).
Samples of specified quantity were placed in platinum crucible with heating range of 25-500 °C having a heating rate of 10 °C min -1 .
Solubility Study of Acyclovir
According to the technique described by Higuchi and Connors solubility study was performed. Six different solvents i.e.Monobasic potassium phosphate buffer having pH 7.4, 7.2 and 6.8, purified water, 0.1 N Hydrochloric acid (HCl) solution and 0.1 N Sodium hydroxide (NaOH) solution were used for solubility.
Acyclovir Tablet Formulation
Acyclovir controlled release tablets (500 mg), comprising 200 mg of Acyclovir and copolymers Ethocel and carbopol were formulated. The tablets were prepared at several drug-to-polymer ratios (D:P ratio of 10:5, 10:6, 10:7, 10:8, 10:9, and 10:10) using the slugging method and wet granulation method. Lactose was added as a diluent and magnesium Stearate (0.5% w/w) was used as a lubricant as given in table 1. After drying, these granules were again passed through #12 mesh screens to avoid formation of any lumps agglomerates. Later on when dried uniform size granules were obtained, lubricant was added to the dried granules of all formulations in specified amount. Final formulations of all ratios were eventually compressed into CR tablets of Acyclovir by single punch tablet machine.
Determination of Tabletting Parameters
After preparation of CR tablets of Acyclovir using wet granulation technique, they were subjected to various quality control tests for their physical characteristics investigation.
Using standard operating procedure as described in USP their disintegration, thickness,, friability and hardness were determined. Digital vernier caliper was used for the thicknesses determination of all formulations. Friability, hardness and disintegration of all formulation were performed according to the standards of United State Pharmacopoeia (USP) protocol;s using hardness Apparatus, Friabililator and Disintegration Apparatus.
In Vitro Drug Release
Acyclovir CR tablets of all formulations were examined using USP Method-1 (Rotating Basket Method) for in vitro release studies. The media used, was 0.1 N HCl which was kept at temperature of 37± 0.5 ºC. 5 ml sample was taken with the help of syringe from each basket at definite intervals of time (1, 2, 3, 6, 8, 9, 10, 12, 15, 18 , 24 hours). 5 ml solvent was added to each basket so that net volume remains constant. All the samples were filtered by membrane filter having size of 0.45 µm before taking their absorbance so that any extra particles or can be removed from samples. Absorbance of all sample were obtained with the help of UV-Visible Spectrophotometer at 254 nm and their percentage releases of each formulation were determined.
In-vitro Release Kinetics
In order to predict the physical mechanism of the Acyclovir in-vitro release behavior of all the formulations prepared with different D:P ratios (10:5, 10:6, 10:7, 10:8, 10:9, and 10:10), release data were compared using the following mathematical models [12] . k1-k4 = Constants ofrelease rates, depending on the kinetic model used.
Mt/M∞ = The fraction of drug released. k5 = Constant for integrating geometric and structural properties of tablets. n = diffusion exponent for characterization of drug release transport mechanism 3. Results and Discussion
Standard Calibration Curve of Acyclovir
The standard calibration curve of Acyclovir was obtained using the method mentioned in previous section.
Using UV-Visible spectrophotometer, absorbance valves of stock solution of Acyclovir and its different dilutions were taken and plotted against its respective concentrations.
Standard calibration curve of Acyclovir was constructed using Microsoft Excel and 
Tabletting Parameters Results
Acyclovir control release tablets were prepared by wet granulation method, at different drug to polymer ratios of 10:5, 10:6, 10:7, 10:8, 10:9, and 10:10. The final formulations were inspected for their different physical characteristics. Tables 2 presented the   thickness, hardness and friability, while table 3 shows the disintegration applied to CR tablets of Acyclovir with Carbopol and Ethocel. All the tablets of above mentioned formulations were well-made in look and were having smooth shiny surfaces. As displayed in table 2, the mean thickness of CR tablets of Acyclovir of all formulations, prepared by wet granulation technique with Carbopol and Ethocel were about 5mm which are within the USP range (2-6mm). All values expressed in mean ± SD Ethocel. The results of all formulations were within USP satisfactory friability range, the mean value of friability was less than 0.8%.
Drug Release Studies
As displayed in figure polymers is due to increases in the viscosity of the gel layer around the matrix tablet [18, 19] . Both polymers have a affinity of making gel when they come into contact with aqueous layer. So, at high levels, polymer concentrations are increased around the tablet, and so is the viscosity of the outer layer, which results in decreases in the release of the drug, which then subsequently limits the release of the drug from the matrix [18] . Gel creation occurs due to dissociation of the carboxyl groups of Carbapol at a pH above their pKa (i.e., 6.0±0.3), which causes uncoiling and the development of molecules due to the production of an electrostatic repulsive force between the negatively charged carboxyl groups. Uncoiling and expansion of the molecules result in polymer swelling and, consequently, gel is formed, which consists of closely packed swollen particles. With increases in the amount of polymer, this gelling property increases, and thicker gel restrains water penetration, which ultimately reduces the release of the drug. At high levels of both polymers, a considerable fraction of the drug (~16%) remained unreleased until 24 hours, which may result in reductions in the extent of bioavailability significantly. Charyulu et al prepared acyclovir controlled release tablets using HPMC K15M and sustained the release for 10 hrs. Similarly CHAUDHARI et al formulated controlled release tablets of acyclovir using hydrophilic polymer, polyethylene oxide and the maximum sustained action was observed for 12 hrs [20, 21] . Acylex ® by Ferozsons (pvt) Ltd Noshehra, Pakistan was used as a reference drug which gave 100% release after 40 Minutes.
Kinetic Analysis of Drug Release Data
Kinetic analysis of drug release data was done by using the mathematical models [19] . It was found that the formulation F6 followed zero order release and formulations F1, F2, F3, F4 and F5 followed first order release as shown in table 4. The data of the various models revealed that formulations F1, F2, F3, F4 and F5 followed Higuchi matrix model whereas formulations F6, follows Korsmeyer-Peppas model. In case of formulation F6 the n value for Korsmeyer-Peppas model was found to be in range less than 0.5, which indicates mechanism of drug release by Fickian diffusion whereas in case of formulations F1, F2, F4 and F5 the n value for Korsmeyer
Peppas model was found to be more than 0.5, which indicates mechanism of drug release by non fickian diffusion by those formulations. The authors are thankful to Leads Pharmaceutical Industries (pvt) Ltd Islamabad for providing the pure sample of acyclovir and necessary research facilities to carry out this work.
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